Symic Biomedical
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
5980 Horton St Ste 600, Emeryville, Cali...Phone Number
(415) 805-9005Website
symic.bioRevenue
$7.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Symic Biomedical
Symic Bio is a biopharmaceutical company developing novel matrix-targeting therapeutics, a new category of therapeutics focused on matrix biology. These therapeutics, with potential applications in a wide variety of disease states, are inspired by naturally occurring macromolecules that play key regulatory roles within the extracellular matrix. Symic Bio currently has two clinical candidates: SB-061, directed at disease modification and pain management in the treatment of osteoarthritis, and SB-030, targeting the prevention of peripheral vein graft failure. In addition, Symic Bio is investigating applications in the areas of fibrosis, oncology and diseases of the central nervous system.Explore more
Symic Biomedical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Symic Biomedical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Symic Biomedical recently announced quarterly report
Click to see if Symic Biomedical had a recent Job posting/layoffs
Check if Symic Biomedical has recently received funding, and reach out quickly before it becomes old news!
Check out if Symic Biomedical is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Symic Biomedical has new funding data
Product Launch: Get notified when Symic Biomedical launches new products
Congratulate Masked Content for being promoted to Masked Content at Symic Biomedical
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Symic Biomedical, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Symic Biomedical
Compare insights from companies similar to Symic Biomedical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Symic Biomedical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Symic Biomedical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Symic Biomedical.
Symic Biomedical financials insights
Gather financial insights about Symic Biomedical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Series A
$15M
2017
Series B
$30M
2019
Unspecified
$11M
Symic Biomedical Tech Stack
A closer look at the technologies used by Symic Biomedical
Most Recent Scoops
Funding
, a biotechnology company, recently secured $11 million in funding. Cell Innovation Partners led the round.
Funding
Funding
Symic Biomedical recently secured $30 million in a Series B funding round.
Funding
Funding
Symic Biomedical recently secured $25 million in a Series A funding round. Lilly Ventures led the investment.
Funding
Funding
Symic Biomedical recently secured $1.5 million in grant funding.
Funding
Funding
Funding
Symic Biomedical News & Media
Symic Bio grabs $11 mln
Emeryville, California-based Symic Bio, a biopharmaceutical company, has raised $11 million. Cell Innovation Partners led the round.Symic Bio Announces Closing of Investment led by CIP
SAN FRANCISCO, April 25, 2019 /PRNewswire/ -- Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced the closing of financings led by Cell Innovation Partners (CIP), a healthcare venture fund started by ReproCELL and Shinsei Bank...Symic Bio Selected for "The Best of The Liver Meeting 2018" at AASLD
SAN FRANCISCO, Nov. 9, 2018 /PRNewswire/ -- Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced that they were selected for "The Best of The Liver Meeting 2018" at the AASLD international liver meeting and will be presenting on its ...Symic Bio to Present at the 10th Annual ChinaBio Partnering Forum
SAN FRANCISCO, April 18, 2018 /PRNewswire/ -- Symic Bio, a biopharmaceutical company developing novel extracellular matrix targeting drugs, today announced that Rinko Ghosh, President and Chief Business Officer, will present an overview of the company pipeline at the 10th Annual...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Symic Biomedical
Sign Up For FreeTo access detailed company insights
Symic Bio is a biopharmaceutical company developing novel matrix-targeting therapeutics, a new category of therapeutics focused on matrix biology. These therapeutics, with potential applications in a wide variety of disease states, are inspired by naturally occurring macromolecules that play key regulatory roles within the extracellular matrix. Sym... Read More
